Document is current
Any future updates will be listed below
-
Authors
Lenaerts, Melissa https://orcid.org/0000-0001-9687-4375
de Mooij, Cornelis M.
Houwers, Janneke B.
Mitea, Cristina
Panosetti, Marco
de Boer, Maaike
Keymeulen, Kristien B. M. I.
Mottaghy, Felix M.
Lobbes, Marc B. I.
Nelemans, Patty J.
Smidt, Marjolein L.
van Nijnatten, Thiemo J. A.
-
Funding
Funding for this research was provided by:
Kankeronderzoeksfonds Limburg
- License Information
-
More Information
Article History
Received: 20 August 2025
Accepted: 25 October 2025
First Online: 5 December 2025
Declarations
:
: This retrospective study was conducted according to the principles of the Declaration of Helsinki (Finland, 2024) and approved by the medical ethics research committee azM/UM. For this retrospective analysis the necessity to obtain informed consent was waived.
: Due to the retrospective design of this study the necessity to obtain informed consent was waived by the medical ethics research committee azM/UM.
: FMM is supported by the German Research Foundation within the framework of Research Training Group 2375 (Tumour-Targeted Drug Delivery; Grant 331065168) and Clinical Research Unit 5011 (“Integrating Emerging Methods to Advance Translational Kidney Research [InteraKD]”; Project 445703531) and reports institutional grants/contracts from GE Precision Healthcare LLC, NanoMab Technology Ltd., Radiopharm Ltd., and Siemens Healthcare not related to the study; and personal/consulting fees from Advanced Accelerator Applications (AAA) GmbH/Novartis, CURIUMTM, NanoMab Technology Ltd., and Telix Pharmaceuticals outside the submitted work. FMM also serves as Associate Editor of EJNMMI research. MLS received institutional research funding not related to this study from Servier, Pharma, Nutricia and Illumina for the microbiota study. TJAvN received speaker honoraria, participation of medical advisory boards and institutional grant support from Bayer and GE Healthcare, not related to the content of this study, and reports consultancy support for Screenpoint Medical, not related to the content of this study.
